AI-immunology platform company
AI-generated insights about Evaxion Biotech A/S from various financial sources
The speaker is extremely bearish, calling it a 'short' and a 'scam' while being skeptical of its business model where 'AI and drugs don't mix.'
The speaker is extremely bearish, calling it a 'short' and a 'scam' while being skeptical of its business model where 'AI and drugs don't mix.'